173 related articles for article (PubMed ID: 29200954)
1. Reprogramming Factors Remodel Melanoma Cell Phenotype by Changing Stat3 Expression.
Wang Y; Mou Y; Zhang H; Wang X; Li R; Cheng Z; Liu X
Int J Med Sci; 2017; 14(13):1402-1409. PubMed ID: 29200954
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming factors induce proliferation and inhibit apoptosis of melanoma cells by changing the expression of particular genes.
Wang Y; Sun HJ; Li RG; Wang XM; Cheng ZQ; Lou N
Mol Med Rep; 2019 Feb; 19(2):967-973. PubMed ID: 30569122
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of virus-free reprogrammed melanoma cells by the piggyBac transposon.
Yin J; Fan Y; Qin D; Xiaocui Bian X; Bi X
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1591-9. PubMed ID: 23571855
[TBL] [Abstract][Full Text] [Related]
4. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
[TBL] [Abstract][Full Text] [Related]
5. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
[TBL] [Abstract][Full Text] [Related]
6. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
[TBL] [Abstract][Full Text] [Related]
7. Emerging methods for preparing iPS cells.
Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
[TBL] [Abstract][Full Text] [Related]
8. Critical roles of Cyclin D1 in mouse embryonic fibroblast cell reprogramming.
Oh HR; Kim J; Kim J
FEBS J; 2016 Dec; 283(24):4549-4568. PubMed ID: 27790870
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
[TBL] [Abstract][Full Text] [Related]
10. MBD3 inhibits formation of liver cancer stem cells.
Li R; He Q; Han S; Zhang M; Liu J; Su M; Wei S; Wang X; Shen L
Oncotarget; 2017 Jan; 8(4):6067-6078. PubMed ID: 27894081
[TBL] [Abstract][Full Text] [Related]
11. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
12. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
13. Gene expression of OCT4, SOX2, KLF4 and MYC (OSKM) induced pluripotent stem cells: identification for potential mechanisms.
Cai Y; Dai X; Zhang Q; Dai Z
Diagn Pathol; 2015 Apr; 10():35. PubMed ID: 25907774
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming bladder cancer cells for studying cancer initiation and progression.
Iskender B; Izgi K; Canatan H
Tumour Biol; 2016 Oct; 37(10):13237-13245. PubMed ID: 27456363
[TBL] [Abstract][Full Text] [Related]
16. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
[TBL] [Abstract][Full Text] [Related]
18. Deoxycholic Acid Upregulates the Reprogramming Factors KFL4 and OCT4 Through the IL-6/STAT3 Pathway in Esophageal Adenocarcinoma Cells.
Chen M; Ye A; Wei J; Wang R; Poon K
Technol Cancer Res Treat; 2020; 19():1533033820945302. PubMed ID: 32869704
[TBL] [Abstract][Full Text] [Related]
19. Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
Ramaswamy K; Yik WY; Wang XM; Oliphant EN; Lu W; Shibata D; Ryder OA; Hacia JG
BMC Res Notes; 2015 Oct; 8():577. PubMed ID: 26475477
[TBL] [Abstract][Full Text] [Related]
20. Targeting of apoptosis gene loci by reprogramming factors leads to selective eradication of leukemia cells.
Wang Y; Lu T; Sun G; Zheng Y; Yang S; Zhang H; Hao S; Liu Y; Ma S; Zhang H; Ru Y; Gao S; Yen K; Cheng H; Cheng T
Nat Commun; 2019 Dec; 10(1):5594. PubMed ID: 31811153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
